Finally, inhibition of the oxysterol pathway, using the CYP7B1 inhibitor clotrimazole, resolved B cell‐driven iBALT formation and attenuated CS‐induced emphysema in vivo in a therapeutic approach. This evidence concerns the gene CYP7B1 and pulmonary emphysema.